Straits Times Index
3,412.00 +44.10 (+1.31%) Nikkei
40,337.52 +262.83 (+0.66%) Hang Seng
17,841.77 +72.63 (+0.41%) FTSE 100
8,121.20 -45.56 (-0.56%) Bitcoin USD
61,981.93 -849.18 (-1.35%) CMC Crypto 200
1,333.20 -11.31 (-0.84%)
NVO Jul 2024 141.000 call
- Yahoo Finance Video
Biden, Sanders call for obesity drug makers to cut prices
President Biden and Sen. Bernie Sanders (D-Vt.) are calling for price cuts on popular GLP-1 weight-loss drugs. Pharmaceutical stocks Novo Nordisk (NVO) — who makes Ozempic and Wegovy — and Eli Lilly (LLY) — who makes Mounjaro and Zepbound — tilt lower on the news. Yahoo Finance Health Reporter Anjalee Khemlani details the political discourse around these obesity treatments, citing President Biden and Senator Sanders' op-ed published in USA Today. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
- Barrons.com
Big Pharma Stocks Sell Off as Biden Calls for Lower Drug Prices
The president called on Novo Nordisk to cut what it charges for Wegovy and Ozempic in an op-edit co-authored with Sen. Bernie Sanders.
- Benzinga
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
The President of the United States, Joe Biden, and Sen. Bernie Sanders, the Senate Chairman of the Health, Education, Labor, and Pensions Committee, have long been vocal about the exorbitant prices the pharmaceutical industry charges for prescription drugs in the U.S. Americans pay the highest prices globally for essential medications, with 1 in 4 unable to afford the prescriptions their doctors recommend, the USA Today highlighted. The argument that high domestic prices subsidize fair prices ab
